Mother's Day Classic - Lilydale

Description

Organiser: Mother’s Day Classic

DISTANCES AND TIMES

WALK for 5.1km - 9:30am

The course will start on the grass area near the community room. From there, participants will walk or run down to the lake circuit where they will complete 2 laps of the lake before returning to the finish line in the event area.The course will start on the grass area near the community room. From there, participants will walk or run down to the lake circuit where they will complete 2 laps of the lake before returning to the finish line in the event area.

About

Over the past 27 years, the Mother's Day Classic community has donated $47.3 million to fund life-saving breast cancer research and ovarian cancer research.

Thanks to research, the five-year survival rate for breast cancer has increased from 84 per cent to 92 per cent since the Mother’s Day Classic started in 1998. There’s still more to be done to achieve the goal of zero deaths from breast cancer.

Tragically, treatment, early detection, and preventative medical research advances for ovarian cancer have been limited. Treatment options and targeted therapies have only marginally improved in 30 years and there is currently no readily available, non-invasive early detection test for ovarian cancer. The average five year survival rate for a woman diagnosed with ovarian cancer is just 49 per cent. Over the past 27 years, the Mother's Day Classic community has donated $47.3 million to fund life-saving breast cancer research and ovarian cancer research.

Thanks to research, the five-year survival rate for breast cancer has increased from 84 per cent to 92 per cent since the Mother’s Day Classic started in 1998. There’s still more to be done to achieve the goal of zero deaths from breast cancer.

Tragically, treatment, early detection, and preventative medical research advances for ovarian cancer have been limited. Treatment options and targeted therapies have only marginally improved in 30 years and there is currently no readily available, non-invasive early detection test for ovarian cancer. The average five year survival rate for a woman diagnosed with ovarian cancer is just 49 per cent.